Performance of a FRET-Based Point-of-Care Immunoassay for the Quantitation of Fecal Calprotectin
2021
A
fast (~5 min), time-resolved fluorescence resonance energy transfer based
immunoassay (Procise FCP™) was developed for the point-of-care
quantitative detection of fecal calprotectin (FCP) using 15 mg of fecal
specimen eluted in collection fluid from the Procise Stool Collection Device™. Studies were performed to characterize
analytical performance of the Procise FCP assay on the ProciseDx™ analyzer.
The
Procise FCP assay showed good analytical performance with respect to
sensitivity, specificity, linearity, and precision suitable for routine
clinical use in a point-of-care setting as well as excellent analytical
agreement with a current commercial FCP measurement method.
Results
indicate that the Procise FCP assay is sensitive, specific, and precise
yielding results in less than 5 minutes. This indicates the Procise FCP assay is
useful for obtaining fast and accurate FCP quantitation, thus avoiding delays
inherent to current methods and enabling immediate clinical assessment to be
made during a single patient visit.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI